Public And Private Payer Perspectives On The Net Cost Of Implementation Of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Compared With 7-Valent Pneumococcal Conjugate Vaccine (PCV7) To In The United States
May 1, 2014, 00:00
10.1016/j.jval.2014.03.1568
https://www.valueinhealthjournal.com/article/S1098-3015(14)01619-2/fulltext
Title :
Public And Private Payer Perspectives On The Net Cost Of Implementation Of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Compared With 7-Valent Pneumococcal Conjugate Vaccine (PCV7) To In The United States
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)01619-2&doi=10.1016/j.jval.2014.03.1568
First page :
A269
Section Title :
Infection
Open access? :
No
Section Order :
1049